175 related articles for article (PubMed ID: 37995179)
1. Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
Yang M; Shen H; Flodby P; Koss MD; Bassiouni R; Liu Y; Jashashvili T; Neely A; Ogbolu E; Castillo J; Stueve TR; Mullen DJ; Ryan AL; Carpten J; Castaldi A; Wallace WD; Zhou B; Borok Z; Marconett CN
Cell Rep; 2023 Dec; 42(12):113286. PubMed ID: 37995179
[TBL] [Abstract][Full Text] [Related]
2. Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma.
Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
Cancer Discov; 2024 Feb; 14(2):308-325. PubMed ID: 37931288
[TBL] [Abstract][Full Text] [Related]
3. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
Juul NH; Yoon JK; Martinez MC; Rishi N; Kazadaeva YI; Morri M; Neff NF; Trope WL; Shrager JB; Sinha R; Desai TJ
Nature; 2023 Jul; 619(7971):860-867. PubMed ID: 37468622
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
Cho HC; Lai CY; Shao LE; Yu J
Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
[TBL] [Abstract][Full Text] [Related]
5. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform.
Naranjo S; Cabana CM; LaFave LM; Romero R; Shanahan SL; Bhutkar A; Westcott PMK; Schenkel JM; Ghosh A; Liao LZ; Del Priore I; Yang D; Jacks T
Genes Dev; 2022 Aug; 36(15-16):936-949. PubMed ID: 36175034
[TBL] [Abstract][Full Text] [Related]
6. Alveolar progenitor and stem cells in lung development, renewal and cancer.
Desai TJ; Brownfield DG; Krasnow MA
Nature; 2014 Mar; 507(7491):190-4. PubMed ID: 24499815
[TBL] [Abstract][Full Text] [Related]
7. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS
Baltanás FC; García-Navas R; Rodríguez-Ramos P; Calzada N; Cuesta C; Borrajo J; Fuentes-Mateos R; Olarte-San Juan A; Vidaña N; Castellano E; Santos E
Nat Commun; 2023 Sep; 14(1):5856. PubMed ID: 37730692
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Differentiation-1 Sustains Mutant
Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
[TBL] [Abstract][Full Text] [Related]
9. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS
Pribluda A; Daemen A; Lima AN; Wang X; Hafner M; Poon C; Modrusan Z; Katakam AK; Foreman O; Eastham J; Hung J; Haley B; Garcia JT; Jackson EL; Junttila MR
Elife; 2022 Aug; 11():. PubMed ID: 35983994
[TBL] [Abstract][Full Text] [Related]
10. Alveolar progenitor cells and the origin of lung cancer.
Sainz de Aja J; Dost AFM; Kim CF
J Intern Med; 2021 May; 289(5):629-635. PubMed ID: 33340175
[TBL] [Abstract][Full Text] [Related]
11. Characterization of
Kim S; Kim J; Jung Y; Jun Y; Jung Y; Lee HY; Keum J; Park BJ; Lee J; Kim J; Lee S; Kim J
Mol Cells; 2020 Jul; 43(7):619-631. PubMed ID: 32638704
[TBL] [Abstract][Full Text] [Related]
12. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations.
Wang T; Guo H; Li Q; Wu W; Yu M; Zhang L; Li C; Song J; Wang Z; Zhang J; Tang Y; Kang L; Zhang H; Zhan J
Cell Rep; 2022 Aug; 40(8):111210. PubMed ID: 36001969
[TBL] [Abstract][Full Text] [Related]
13. p53 governs an AT1 differentiation programme in lung cancer suppression.
Kaiser AM; Gatto A; Hanson KJ; Zhao RL; Raj N; Ozawa MG; Seoane JA; Bieging-Rolett KT; Wang M; Li I; Trope WL; Liou DZ; Shrager JB; Plevritis SK; Newman AM; Van Rechem C; Attardi LD
Nature; 2023 Jul; 619(7971):851-859. PubMed ID: 37468633
[TBL] [Abstract][Full Text] [Related]
14. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
15. Club cells employ regeneration mechanisms during lung tumorigenesis.
Chen Y; Toth R; Chocarro S; Weichenhan D; Hey J; Lutsik P; Sawall S; Stathopoulos GT; Plass C; Sotillo R
Nat Commun; 2022 Aug; 13(1):4557. PubMed ID: 35931677
[TBL] [Abstract][Full Text] [Related]
16. Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation.
He Q; Qu M; Xu C; Wu L; Xu Y; Su J; Bao H; Shen T; He Y; Cai J; Xu D; Zeng LH; Wu X
Cancer Lett; 2024 Jun; 592():216922. PubMed ID: 38704137
[TBL] [Abstract][Full Text] [Related]
17. Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma.
Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
bioRxiv; 2023 Oct; ():. PubMed ID: 37808711
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation.
Xu L; Ding R; Song S; Liu J; Li J; Ju X; Ju B
J Gene Med; 2024 Jan; 26(1):e3658. PubMed ID: 38282149
[TBL] [Abstract][Full Text] [Related]
19. YTHDF1 Promotes Cyclin B1 Translation through m
Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
[TBL] [Abstract][Full Text] [Related]
20. PKC
Garg R; Cooke M; Benavides F; Abba MC; Cicchini M; Feldser DM; Kazanietz MG
Cancer Res; 2020 Dec; 80(23):5166-5173. PubMed ID: 32994205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
